
|Articles|January 29, 2016
Frequently Asked Questions About Pharmacy DIR Fees
Government affairs strategist Ron Lanton III, Esq, interviews Susan Pilch, vice president of policy and regulatory affairs for the National Community Pharmacists Association, about direct and indirect remuneration fees.
Advertisement
Government affairs strategist Ron Lanton III, Esq, interviews Susan Pilch, vice president of policy and regulatory affairs for the National Community Pharmacists Association, about direct and indirect remuneration fees.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























